The incidence of atopic diseases, including atopic dermatitis (AD), food allergies, allergic rhinitis, and asthma, has increased in recent decades, and currently affects approximately 20% of the population.
Introduction
The incidence of atopic diseases, including atopic dermatitis (AD), food allergies, allergic rhinitis, and asthma, has increased in recent decades. Currently, atopic diseases affect approximately 20% of the population. Allergic march is defined as development of AD in infancy and subsequent food allergies, allergic rhinitis, and asthma in later childhood 1 . Patients with infantile eczema may develop typical symptoms of AD, allergic rhinitis, and asthma at certain ages. Some patients' symptoms persist for several years, whereas others may experience resolution with aging 2 . Development of these diseases is strongly influenced by several factors, including genetic and environmental factors 3, 4 . This review will address the cause of development of allergic march from the perspective of two factors: skin dysfunction and microflora in early infancy.
We focused on these two factors because they strongly affect both a decreased Th1/Th2 pattern and decreased regulatory T cells in early infancy.
Development of Allergic March and Skin Dysfuntion Filaggrin Mutations and Atopic March
Epidermal differentiation complex is caused by independent loss-of-function genetic variants (R510X and 2282del4) in the gene encoding filaggrin, which is a key structural protein in the outermost layer of the epidermis in up to 50% of patients with AD 5 . Recent genetic studies have shown a major role of filaggrin in the pathogenesis of AD and in subsequent progression of atopic march 6 .
Filaggrin mutations are currently considered as a major risk factor for AD, particularly in patients who have onset of AD at 2 years or younger 7 . A recent study showed a significant association of two filaggrin gene mutations with asthma and allergic rhinitis 8 . However, this associa-tion was only found in subjects with co-existing AD and the association was not obvious without co-existing AD 8 .
Additionally, the human bronchial epithelium does not express filaggrin protein 9, 10 . Therefore, filaggrin mutations do not appear to exert effects in the upper airway. The association of filaggrin mutations with other atopic disorders appears to be due to the common feature of allergen sensitization through the skin. The fact that asthma is only found in a population of filaggrin mutation carriers with AD supports the hypothesis that asthma follows allergic sensitization that occurs after impairment of the epidermal skin barrier. Filaggrin mutations are likely to play a role in chronicity of the disease and immunoglobulin E (IgE) sensitization in patients with AD. Recent studies have shown that patients with early-onset AD and filaggrin mutations are likely to have persistent allergic disease into adulthood 11 . Patients with AD and filaggrin mutations are significantly associated with the extrinsic form of the disease (IgE-mediated sensitization to inhalants or food allergens) and development of allergic rhinitis and asthma 12 14 .
The finding of filaggrin mutations predisposing to asthma, allergic rhinitis, and allergic sensitization only in the presence of AD strongly supports the role of filaggrin in the pathogenesis of AD and subsequent progression of atopic march. Expression of the filaggrin gene is downregulated in AD skin by Th2 cytokines (interleukin [IL]-4 and IL-13) 15 and in normal human keratinocytes by sphingosylphosphorylcholine, a proinflammatory cytokine in AD 16, 17 . These findings indicate that filaggrin defects can develop as an acquired and/or genetic defect.
However, almost 40% of carriers of filaggrin mutations do not have AD 18 . Additionally, patients with the inherited skin disorder ichthyosis vulgaris, who have filaggrin mutations, do not have AD-like skin inflammation or infection 19 . Therefore, additional factors may affect the pathogenesis of AD.
Infantile Eczema and Its Association with Development of Atopic March
Ekbäck et al 20 showed that infantile eczema with high scoring atopic dermatitis (SCORAD) points (scoring of AD severity) was associated with an increased risk of asthma at 10 years of age. Children with eczema and wheezing episodes during infancy are more likely to develop asthma than infants with eczema alone. Eczema in infancy, combined with an early onset of allergic rhinoconjunctivitis, appears to indicate a more severe allergic disease, which often leads to progression of asthma. Progression from eczema in infancy, to allergic rhinoconjunc-tivitis at an early age and asthma later in childhood, supports the relevance of the term atopic march , at least in more severe allergic disease. The first unselected birth cohort study showed that eczema in the first year of life was associated with asthma at 6 years old in girls and boys 21 . Since this study report, multiple birth cohort studies have reported the march from eczema to other allergic diseases. The Tucson Children's Respiratory Study of an unselected birth cohort showed that eczema at the age The MAS followed a birth cohort, which comprised children with a family history of allergies. The MAS showed that eczema in the first 2 years of life was related to an increased risk of current wheeze at 7 years (OR 1.93; 95% CI 1.22 3.06). However, Illi et al 24 found no evidence for an association between eczema and asthma at 7 years old once they adjusted for early wheeze and early-life sensitization (OR 1.46; 95% CI 0.73 2.90). The authors argued that eczema was not an independent risk factor for subsequent asthma, and attributed the association to confounding by early wheeze and sensitization that co-manifested with early-life eczema.
A study of children with a family history of allergies, the Melbourne Atopic Cohort Study (MACS) 25 , showed a similar pattern when analyzed in the same manner as the MAS 24 . In the MACS, eczema in the first 2 years of life was associated with an increased risk of asthma at 6 7 years old (OR 2.02; 95% CI 1.33 3.07), but after adjustment for early-life wheeze and sensitization, this association was not significant (OR 1.45; 95% CI 0.92 2.31).
However, further analysis showed that early-life eczema remained associated with an increased risk of childhood asthma, when adjusted only for early-life wheeze (OR 1.83; 95% CI 1.17 2.85). This finding suggested that the major cause of confounding was sensitization. This study also showed that, independent of wheeze and sensitization, AD within the first 2 years of life was associated with an increased risk of childhood asthma in boys (OR 2.45 95% CI, 1.31 4.46), but not girls.
Whether sensitization should be considered a confounder between early-life eczema and the risk of other forms of allergic disease remains controversial. Eczema may precede and increase the risk of subsequent sensitization, which in turn increases the risk of asthma, as discussed above. Therefore, sensitization that follows eczema is likely to be a step in the biological pathway between eczema and asthma, but not a confounder. Adjusting for early-life sensitization without considering the temporal sequence of sensitization and eczema will underestimate the effect of eczema on asthma. The interest raised by the manifestation argument by the MAS prompted a systematic review and meta-analysis of the evidence on atopic march 26 . This review included four population-based cohort studies 23,27 30 that achieved an 80% follow-up. This review showed that young children with AD have an elevated risk of developing asthma (pooled OR 2.14; 95% CI 1.76 2.75).
Epidermal barrier dysfunction and the keratinocytederived cytokine thymic stromal lymphopoietin may also play critical roles in the onset of atopic march followed by development of asthma 30 .
Prevention of Atopic March
Primary prevention of allergic disease has been studied for many years. However, studies of avoidance of food allergens, aeroallergens, or both, have generally produced disappointing results 31 
Cutaneous Microbiota and Skin Dysfunction
A recent study showed that the skin microbiota plays a crucial role in skin function and also a loss in diversity of the microbiota, resulting in chronic inflammation on and in the skin 33 . Water is crucial to growth of the microbiota on the skin and for maintaining diversity of the skin microbiota. Bacteria on the skin are from four main bacterial phyla: actinobacteria, firmicutes, proteobacteria, and bacteroidetes. The three most common genera are corynebacteria, propionibacteria, and staphylococci 34 .
Water activity varies from 0 (no free water available) to 1.0 (all molecules of water are free) 35 . Water activity strongly affects growth of microorganisms and differs considerably between the main environments of human skin 36 months of age in infants with breast-feeding and gradually increase at 6 months of age. The percentage of these bacteria is greater than 90%. With introduction of baby food, the numbers of Escherichia coli, streptococci, clostridium, bacteroides, and anaerobic bacteria have increased. There is no difference in the number of these bacteria between breast feeding and artificial feeding.
Surprisingly, a large cohort study showed shared features of functional maturation of the gut microbiome during the first 3 years of life in healthy children and adults from the Amazonas of Venezuela, rural Malawi, and US metropolitan areas 41 .
Change in Microflora during Growth According to

Environmental Factors
Immediately after virginal birth, the newborn intestine is colonized by microflora, which are from vaginal flora and microflora in the mother 39 . In healthy infants, species of lactobacillus or bifidobacterium are predominantly found. In breast-fed infants, the number of bifidobacteria is 10 times greater than that in formula-fed infants at 1 month of age 42 
Effect of Development of a Th1/Th2 Pattern in Infancy on Atopic March
Atopic disease, including AD, BA, FA and AR, may be caused by production of antigen-specific immunoglobulin production (IgE) associated with failure of T cell immunotolerance. In fetuses and neonates, the immunological status shows a Th2 pattern rather than Th1. Subsequently, the normal immunoresponse moves to the Th1 pattern. If the pattern of Th2 does not move to that of Th1, atopic march associated with production of IgE antibody begins in early infancy 50 . IL-12, which changes naive T cells to Th1 cells, is produced by antigen-presenting cells stimulated by lipopolysaccharide through Toll-like receptor 4. In childhood, the capacity of production of IL-12 is lower than that in adults 50 . Therefore, this phenomenon may be one of the causative factors for easily shifting from the pattern of Th1 to that of Th2.
Oral Immunotolerance and Microflora
Oral immunotolerance is one of the immunoresponses characterized by intestinal immune phenomena. After the intake of allergen, the same allergen was administrated parentally, and this response was markedly suppressed compared with no intake of allergen. In the germfree mouse, inducing immunotolerance is difficult 51 . One of the representative microflora, Bifidobacterium infantis, in-duces immunotolerance for colonization in germfree mouse intestine 51 . Hori S et al 52 showed that natural regulatory T (Treg) cells play a crucial role in immunological self-tolerance and homeostasis in humans. Furusawa et al 53 found that in a mouse model, clostridium species increased the number and percentage of Treg cells that were mediated by transforming growth factor-β. After colonization of this species in early life, the production of IgE was subsequently suppressed. They also reported that short chain fatty acids produced by these species can cause differentiation of Treg from naive T cells, which is mediated through histone acetylation of FOX P genes.
Therefore, some microflora may be significantly related to induction of oral immunotolerance. Another study reported development of Treg cell subsets during the first postnatal year. In healthy children, in the first year of age, Treg cells gradually increase from 6 months to 1 year old, and do not change in the adult 55 .
Development of Treg Subsets and Dysregulation of
Effect of Probiotics on Allergic Disease
Development of atopic disease is observed in early infancy. In atopic march, administration of probiotics may be expected to be useful. Administration of probiotics in early life may be an effective method for preventing AD, but little is known about its long-time preventive effect.
A meta-analysis was conducted to evaluate the long-term effect of early-life supplementation with probiotics on preventing AD 56 . Six trials and a total of 1,955 patients were included in this meta-analysis. The combined risk ratio of the meta-analysis that compared probiotics with placebo to investigate the long-term preventive effect of AD was 0.86 (95% CI 0.77 0.96). This finding demonstrates that probiotics are likely to cause long-term prevention of AD. Another study suggested that probiotics have shown more promise, albeit limited, in the primary prevention of allergic disease than in the treatment of established disease 57 .
Effect of Probiotics for Immunotherapy
Most children who develop food allergies in infancy outgrow these food allergies before school age. Approximately 50% of children can tolerate allergic food by 5 years old, increasing to 75% by their early teenage years 58 . Nevertheless, some children experience persistent allergic reactions 59, 60 . Oral immunotherapy (OIT) is regularly used for young children with food allergies and has been shown to be effective 61 70 in early infancy to adults. This is because the composition of microflora in the intestines may be not be changeable after 3 years old 41 . Skin barrier dysfunction in early infancy, representing high transepidermal water loss, persists until 1year old 75 . Skin dysfunction might gradually improve before school age, similar to adult skin function 75 . Therefore, in early infancy, massive allergen expo-sure to the skin induces sensitization of allergens and also produces IL-4, followed by allergen-mediated IgE production. If a normal balance of microflora is present in the gut in infancy, it improves this Th2-dominant pattern in the fetus 76 . Th1 and Th2 lymphocytes are thought to be differentiated from naive T cells. Therefore, as early as possible, the Th1/Th2 pattern may easily change by a change in microflora. Several studies on administration of probiotics have been performed to prevent the onset of allergic disease. The effect of probiotics was observed when they were administrated in early infancy and late pregnacy 56, 57 . The effect of probiotics may be explained by the fact that naive T cells may more easily change to Th1 instead of Th2. After complete colonization of microflora, maybe by 3 years old, there might be no effect of immunological change, with no changeable composition of microflora.
A recent study showed that fecal transplantation was curable in C. difficile infection-related diarrhea 77 . Although there are no data for using fecal transplantation in fetuses, this transplantation may be useful for curing allergic disease, such as food allergies, grass pollens, and allergic asthma.
Conclusion
Massive allergen exposure to skin genetic dysfunction in early infancy and an imbalance in microflora are necessary for development of atopic march. Therefore, application of skin moisturizer and use of steroid ointment, as well as administration of probiotics during pregnancy and early infancy, may be useful for preventing development of this march. However, further studies are required to evaluate the effects of these treatments.
